Ensysce Biosciences (ENSC) EBITDA (2017 - 2026)
Ensysce Biosciences (ENSC) EBITDA from Sep 30, 2017 to Mar 31, 2026. The TTM Ensysce Biosciences (ENSC) EBITDA is -$12M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Ensysce Biosciences (ENSC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +72.20% |
| 3 Years TTM | -22.57% |
Annual EBITDA change of Ensysce Biosciences (ENSC)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$3.56M | -65.20% |
| 2025 | -$10M | +52.01% |
| 2024 | -$6.73M | -37.22% |
| 2023 | -$11M | -55.74% |
| 2022 | -$24M | +21.89% |
| 2021 | -$20M | -535.75% |
| 2020 | $4.56M | -994.12% |
| 2019 | -$510K | -119.03% |
| 2018 | $2.68M | -9033.33% |
| 2017 | -$30K | N/A |